Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine
Open Access
- 1 September 2008
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 3 (4), 397-401
- https://doi.org/10.2147/ijn.s3259
Abstract
Peer reviewed article authored by (Melanie Kripp, Ralf-Dieter Hofheinz). Read article or submit your manuscript for publishing.Keywords
This publication has 28 references indexed in Scilit:
- Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developmentsExpert Opinion on Pharmacotherapy, 2008
- Nucleoside analogues in the treatment of haematological malignanciesExpert Opinion on Pharmacotherapy, 2001
- Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.1999
- Liposomes as carriers of antitumor agents: Toward a clinical realityCancer Treatment Reviews, 1989
- MULTIVESICULAR LIPOSOMES CONTAINING 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR SLOW-RELEASE INTRATHECAL THERAPY1987
- Cytosine arabinoside cerebrospinal fluid kineticsClinical Pharmacology & Therapeutics, 1984
- Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol componentsLife Sciences, 1982
- Neurotoxicity of Commonly Used Antineoplastic AgentsNew England Journal of Medicine, 1974
- Phospholipid spherules (liposomes) as a model for biological membranesJournal of Lipid Research, 1968
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965